Explore the molecular pharmacology and antitumor activity of PHT-427, a novel dual-targeting inhibitor of Akt and PDPK1 with promising cancer therapeutic potential.
Explore how dual targeting of HDAC6 and Hsp90 proteins creates a powerful approach to combat treatment-resistant cancers through synergistic mechanisms.
Discover how the cancer drug 5-aza-2'-deoxycytidine's toxicity comes from DNA methyltransferase trapping rather than DNA demethylation, reshaping epigenetic therapy approaches.
Explore how bioorthogonal glycoengineering-mediated liquid metal nanoprobes are revolutionizing cancer therapy through precise targeting and multifunctional treatment approaches.
Explore how glycocholic acid-modified micelles enable oral delivery of gemcitabine for cancer therapy, overcoming bioavailability challenges through nanotechnology.
Explore how pH-sensitive nanoparticles are transforming cancer therapy by delivering drugs precisely to tumors while minimizing side effects.
Exploring pillararene-based supramolecular delivery systems for targeted cancer therapy with reduced side effects
Discover how dialkynylimidazoles are redefining targeted cancer therapy through irreversible MAPK inhibition and molecular probing.
Explore how light-activated nanomaterials are revolutionizing cancer treatment through precise targeting and reduced side effects.
Discover how Escherichia coli L-asparaginase evolved from a bacterial enzyme to an essential cancer therapy for acute lymphoblastic leukemia through structural biology insights.